ANI Pharmaceuticals
ANIP
#4819
Rank
S$2.37 B
Marketcap
S$105.97
Share price
-1.17%
Change (1 day)
41.39%
Change (1 year)

Operating Margin for ANI Pharmaceuticals (ANIP)

Operating Margin as of December 2025 (TTM): 6.11%

According to ANI Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 6.11%. At the end of 2024 the company had an Operating Margin of -3.62%.

Operating Margin history for ANI Pharmaceuticals from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-3.62%-188.57%
20234.08%-120.61%
2022-19.81%-23.63%
2021-25.94%108.27%
2020-12.45%-914.76%
20191.53%-84.63%
20189.95%7.59%
20179.24%37.03%
20166.75%-76.31%
201528.48%-17.76%
201434.62%8166.32%
20130.42%-100.03%
2012-1,210.03%-89.8%
2011-11,859.66%535.2%
2010-1,867.09%-38.87%
2009-3,054.36%541.07%
2008-476.45%-72.93%
2007-1,760.34%-7489.15%
200623.82%-100.66%
2005-3,600.61%-77.14%
2004-15,749.47%70.61%
2003-9,231.29%6764.93%
2002-134.47%-15.65%
2001-159.43%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Jazz Pharmaceuticals
JAZZ
-16.91%-376.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-38.15%-724.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
-7.76%-227.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
12.60% 106.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-43.36%-809.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-2,248.76%-36,904.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
0.52%-91.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12% 376.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
67.31% 1,001.64%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.